Evidence map›Paper›PMID 24515801›Full record

ArticleMolecular cancer research : MCR2014

The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells.

Syng-Ook Lee, Un-Ho Jin, Jeong Han Kang, Sang Bae Kim, Aaron S Guthrie, Sandeep Sreevalsan, Ju-Seog Lee, Stephen Safe

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 107 citations in OpenAlex.

  1. Metabolites · 2026
    Article
  2. Article
  3. Nr4a1 β-cell specific deletion impairs glucose tolerance in female mice.American journal of physiology. Endocrinology and metabolism · 2026
    Article
  4. Article
  5. Article
  6. 7,7-Bis(3-Indolyl)-Journal of microbiology and biotechnology · 2025
    Article
  7. Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Thioredoxin Domain Containing 5 (TXNDC5): Friend or Foe?Current issues in molecular biology · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Syng-Ook Lee *Institute of Bioscience and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
Un-Ho Jin *Institute of Bioscience and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
Jeong Han KangLaboratory of Cell Biology, NCI, National Institutes of Health, Bethesda, MD 20892, USA.
Sang Bae KimDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Aaron S GuthrieDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
Sandeep SreevalsanDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, USA.
Ju-Seog LeeDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Stephen SafeInstitute of Bioscience and Technology, Texas A&M Health Science Center, Houston, TX 77030, USA.
The University of Texas MD Anderson Cancer Center · USNational Institutes of Health · USKeimyung University · KRTexas A&M Health Science Center · USTexas A&M University · US

Funding

NUR77 Agonists: New Targets for Pancreatic Cancer ChemotherapyR01CA124998 · NCI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SAFE, STEPHEN H. · 2007 to 2011
$1.1M
NCI NIH HHS R01 CA124998NCI NIH HHS R01-CA124998
6 · The paper itself

Abstract

unlabelledNR4A1 (Nur77, TR3) is an orphan nuclear receptor that is overexpressed in pancreatic cancer and exhibits pro-oncogenic activity. RNA interference of NR4A1 expression in Panc-1 cells induced apoptosis and subsequent proteomic analysis revealed the induction of several markers of endoplasmic reticulum stress, including glucose-related protein 78 (GRP78), CCAAT/enhancer-binding protein-homologous protein (CHOP), and activating transcription factor-4 (ATF-4). Treatment of pancreatic cancer cells with the NR4A1 antagonist 1,1-bis(3'-indolyl)-1-(p-hydroxyphenyl)methane (DIM-C-pPhOH) gave similar results. Moreover, both NR4A1 knockdown and DIM-C-pPhOH induced reactive oxygen species (ROS), and induction of ROS and endoplasmic reticulum stress by these agents was attenuated after cotreatment with antioxidants. Manipulation of NR4A1 expression coupled with gene expression profiling identified a number of ROS metabolism transcripts regulated by NR4A1. Knockdown of one of these transcripts, thioredoxin domain containing 5 (TXNDC5), recapitulated the elevated ROS and endoplasmic reticulum stress; thus, demonstrating that NR4A1 regulates levels of endoplasmic reticulum stress and ROS in pancreatic cancer cells to facilitate cell proliferation and survival. Finally, inactivation of NR4A1 by knockdown or DIM-C-pPhOH decreased TXNDC5, resulting in activation of the ROS/endoplasmic reticulum stress and proapoptotic pathways. IMPLICATIONS: The NR4A1 receptor is pro-oncogenic, regulates the ROS/endoplasmic reticulum stress pathways, and inactivation of the receptor represents a novel pathway for inducing cell death in pancreatic cancer.

Indexed as

ApoptosisCell Growth ProcessesCell Line, TumorEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressGene Expression Regulation, NeoplasticGene SilencingHumansIndolesMicroscopy, Electron, TransmissionNuclear Receptor Subfamily 4, Group A, Member 1Oxidative StressPancreatic NeoplasmsPhenolsProtein Disulfide-IsomerasesReactive Oxygen Species1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methaneEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanIndolesNR4A1 protein, humanNuclear Receptor Subfamily 4, Group A, Member 1PhenolsProtein Disulfide-IsomerasesReactive Oxygen SpeciesTXNDC5 protein, human

Identifiers

PMID24515801
PMCPMC4407472
OpenAlexW2107976327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.